ACE and hydrops fetalis: An observational study showed that during admission to general, geriatric, or rehabilitation services, 60% of patients (n = 45) aged > 75 years with a high frailty risk and HF were deprescribed angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs).31